ArticlePituitary2026
Management-specific outcome evaluation of pituitary apoplexy; conservative and surgical approach.
Article in Pituitary, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePituitary apoplexy can be managed by early surgery or a conservative approach, if necessary, followed by later elective surgery. Choice of management is related to correct diagnosis, symptom severity at presentation and symptom development prior to contacting the pituitary center of excellence (PTCOE). Specific circumstances may dictate a specific choice, in others shared decision-making is key. This retrospective cohort study aimed to describe clinical decision-making and outcomes of pituitary apoplexy treatment.
methodsOutcome measures were factors relevant to treatment choice, visual acuity (VA), visual field defects (VFD), cranial nerve palsies, pituitary function, measured at three time points (baseline, 6 months after diagnosis, last follow-up).
resultsWe studied 98 patients with clinical apoplexy diagnosed between 2005 and 2021. After the first clinical evaluation, 45 patients underwent early surgery and 53 initial conservative management. Main indications for early surgery were lowered VA and/or severe VFD. Postoperatively, mean VA improved from 0.63 (SD = 0.36) to 1.03 (SD = 0.3). VFD improved in 72.2% of patients. During continued follow-up, 21 initially conservatively treated patients had later elective surgery. VFD improved in 85.7% of these patients. Mean follow-up was > 38 months for each group.
conclusionThe choice for surgery is mainly driven by ophthalmological symptoms, in which severity determines its timing. Although ophthalmological recovery rates are reasonable, (endocrine) outcomes of apoplexy are unfavorable, irrespective of trajectory. Prospective studies are needed to assess optimal (timing of) treatment, in particular in those patients without an obvious reason for early surgery, taking into account the heterogeneity and variable course of this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.